The First-and-Only
Biologic Approved for the
Treatment of Eosinophilic
Esophagitis (EoE)

DUPIXENT is indicated for the treatment of adults and pediatric patients aged 12+ who weigh at least 88 lb (40 kg) with eosinophilic esophagitis (EoE).

Not actual patients

Based on clinical trials with 240 adult and
pediatric patients with eosinophilic
esophagitis (EoE).

A Breakthrough EoE Treatment

Eosinophilic esophagitis (EoE) is a chronic condition that can damage the esophagus over time. People with EoE have more
inflammation than normal in the esophagus, which can lead to difficulty swallowing and other symptoms.

Pills, slurries, and food elimination diets may provide symptom relief. DUPIXENT helps reduce EoE symptoms:

DUPIXENT targets an underlying source of inflammation, which is a cause of EoE
DUPIXENT is a weekly injectable treatment given under the skin (subcutaneous injection). It is not a steroid or immunosuppressant.

Have a productive
Conversation With
Your Doctor

Our goal is for you or your loved one to get the most out of your visit to your doctor. Download this doctor discussion guide to help yourself have a productive conversation during your next visit.

Get More Support With DUPIXENT MyWay®

Once your doctor prescribes DUPIXENT, you can enroll in the DUPIXENT MyWay program, which offers access to a variety of helpful resources.

Tips, tools, and resources from Nurse Educators
Supplemental injection training online or in person
One-on-one nursing support for DUPIXENT
Help scheduling deliveries and monthly prescription refills
Helpful support and resources about DUPIXENT

Learn More About